1887

n South African Medical Journal - The value of genetic testing for inherited retinal disease caused by mutations in the gene in South Africans : correspondence

Volume 103, Issue 10
  • ISSN : 0256-9574
USD

 

Abstract

Gene-based therapies for inherited retinal degenerative diseases (RDDs) have gained momentum in the past 5 years, and there are currently several early-stage clinical trials underway that have the potential to intervene in disease processes and provide clinical benefit to patients. However, knowledge of a patient's specific underlying genetic mutation(s) is a prerequisite for participation in these trials. Identification of the mutations in patients with RDDs is challenging and costly; there are more than 200 genes associated with RDDs, and each can carry hundreds of potential mutations. Finding the one or two mutations responsible for the RDD in a patient is daunting, so the best candidate gene to screen is often determined by the clinical manifestations of the disease and the inheritance pattern observed.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/m_samj/103/10/EJC142597
2013-10-01
2016-12-11

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error